MERCK AND CO INC news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

MRK 42.85 +0.25 (0.59%)
price chart
Merck lays off 600 more employees at North Wales, Lansdale offices
The Philadelphia Business Journal says the information comes from a Worker Adjustment and Retraining Notification (WARN) notice the pharmaceutical company filed with the Pennsylvania Department of Labor and Industry. Merck officials were not ...
Related articles »  
Merck & Co. Inc.: I'm Long, But It Screams Overvalued Today (MRK)
... I wrote that article at the beginning of 2014 I felt KO was undervalued, purchased it and am now sitting on a nice 8.2% return, excluding dividends, in just over half a year.
Merck & Co., Inc. (MRK) Declares Quarterly Dividend of $0.44  WKRB News
Merck Announces Fourth-Quarter 2014 Dividend  The Wall Street Transcript
Related articles »  
Merck Looks Overpriced Compared To This Sector Peer
Merck (NYSE:MRK) provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide.
Company Update: Merck & Co Inc (NYSE:MRK) � Merck Initiates Phase 3 Study ...
Merck & Co Inc (NYSE:MRK) [Business Wire] - Merck , known as MSD outside the United States and Canada, today announced that the first patient has been enrolled in a global Phase 3 clinical study of letermovir , an investigational antiviral agent.
Related articles »  
Interesting August Stock Options for Merck
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co Merck & Co., Inc (NYSE: MRK). So this week we highlight one interesting put contract, and one interesting call contract ...
Related articles »  
Stock Highlights: Celgene Corporation (NASDAQ:CELG), Merck & Co. Inc ...
Celgene Corporation (NASDAQ:CELG) released its earnings data on Thursday. The company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.01, AnalystRatingsNetwork reports.
Related articles »  
Should Dividend Investors Eject Merck & Co., Inc?
Merck (NYSE: MRK ) has one of the largest dividends in health care, but does that make it one of the sector's top dividend stocks?
Related articles »  
Investors Watch List � Pfizer Inc. (NYSE:PFE), Merck & Co. Inc. (NYSE:MRK ...
Shares of Pfizer Inc. (NYSE:PFE) have received a consensus rating of �Buy� from the seventeen ratings firms that are covering the company, Stock Ratings Network reports. Six analysts have rated the stock with a hold recommendation and nine have ...
Related articles »  
Merck: Buy The Dip... But Not Yet (MRK)
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide.
Insider Selling: Merck & Co. Insider Sells 72290 Shares of Stock (MRK)  Ticker Report
Merck & Co. Given New $61.00 Price Target at Barclays (MRK)  Watch List News (press release)
Related articles »  
Potentials at Drug Manufacture- Merck & Co., Inc. (NYSE:MRK), Eli Lilly and Co ...
Merck & Co., Inc. (NYSE:MRK) [Trend Analysis] after opening at $57.92 hit its intraday high price of $58.34 moreover then finished at $58.34 by shares raised 1.28%.
Drug Most Active Stocks: AbbVie (NYSE:ABBV), Pfizer Inc. (NYSE:PFE), JNJ ...  Crazy Joys
Related articles »